Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/11/2023 | Immix Biopharma, Inc. | | Grant | Stock Options | 20k | $1.86 | $37.2k | | 08/11/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 21.5k | $29.02 | $624.7k | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 1.1k | $36.32 | $39.3k | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 30k | $6.70 | $201k | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Common Stock | 2.7k | $0.00 | $0 | | 06/16/2023 |
05/19/2023 | Prometheus Biosciences, Inc. | RXDX | Grant | Common Stock | 2.2k | $0.00 | $0 | | 05/19/2023 |
07/14/2022 | Immix Biopharma, Inc. | | Grant | Stock Options | 16k | $2.64 | $42.2k | | 07/14/2022 |
05/19/2022 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Option (Right to Buy) | 21.5k | $29.02 | $624.7k | | 05/19/2022 |
11/14/2021 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Option (Right to Buy) | 1.1k | $36.32 | $39.3k | | 11/14/2021 |
03/16/2021 | Prometheus Biosciences, Inc. | RXDX | Purchase | Common Stock | 500 | $19.00 | $9.5k | | 03/16/2021 |